About Us Services Careers FAQ Contact Us 0
Home Medical Devices North America Clinical Trial Imaging Market Size, Share, and Forecast 2030
North America Clinical Trial Imaging Market
Select Regional / Country Report
Global Asia Pacific Europe North America

North America Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Product and Services (Services, Software), By Application (Oncology, Neurology, Endocrinology, Cardiology, Dermatology, Haematology), By Modality (Computed Tomography, Magnetic Resonance Imaging, Echocardiography, Nuclear Medicine, Positron Emission Tomography, X-Ray, Ultrasound, Optical Coherence Tomography, Others), By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Government Research Institutes, Medical Device Manufacturers, Others) and By Country(US, Canada) Forecasts, 2024-2032

Report Code: SRMD3301DR
Last Updated : January 08, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
  2. ESG Trends
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Services
        1. By Value
      3. Software
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Clinical Trial Design and Consultation
        1. By Value
      3. Reading and Analytical
        1. By Value
      4. Operational Imaging
        1. By Value
        2. Computed Tomography (CT) Scan
          1. Computed Tomography (CT) Scan By Value
        3. MRI (Magnetic Resonance Imaging)
          1. MRI (Magnetic Resonance Imaging) By Value
        4. X-Ray
          1. X-Ray By Value
        5. Ultrasound
          1. Ultrasound By Value
        6. Optical Coherence Tomography (OCT)
          1. Optical Coherence Tomography (OCT) By Value
        7. Others
          1. Others By Value
      5. System and Technology Support
        1. By Value
      6. Project and Data Management
        1. By Value
    4. By Application
      1. Introduction
        1. Application By Value
      2. Nonalcoholic Steatohepatitis (NASH)
        1. By Value
      3. Chronic Kidney Disease (CKD)
        1. By Value
      4. Diabetes
        1. By Value
      5. Cardiovascular Diseases
        1. By Value
      6. Oncology
        1. By Value
      7. Neurology
        1. By Value
      8. Endocrinology
        1. By Value
      9. Dermatology
        1. By Value
      10. Hematology
        1. By Value
      11. Others
        1. By Value
    5. By End-Use
      1. Introduction
        1. End-Use By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Medical Devices Manufacturers
        1. By Value
      4. Academic and Government Research Institutes
        1. By Value
      5. Contract Research Organizations (CROs)
        1. By Value
      6. Others
        1. By Value
    6. By Distributor
      1. Introduction
        1. Distributor By Value
      2. Direct Sales
        1. By Value
      3. Tender Sales
        1. By Value
    7. US
      1. By Product
        1. Introduction
          1. Product By Value
        2. Services
          1. By Value
        3. Software
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Clinical Trial Design and Consultation
          1. By Value
        3. Reading and Analytical
          1. By Value
        4. Operational Imaging
          1. By Value
          2. Computed Tomography (CT) Scan
            1. Computed Tomography (CT) Scan By Value
          3. MRI (Magnetic Resonance Imaging)
            1. MRI (Magnetic Resonance Imaging) By Value
          4. X-Ray
            1. X-Ray By Value
          5. Ultrasound
            1. Ultrasound By Value
          6. Optical Coherence Tomography (OCT)
            1. Optical Coherence Tomography (OCT) By Value
          7. Others
            1. Others By Value
        5. System and Technology Support
          1. By Value
        6. Project and Data Management
          1. By Value
      3. By Application
        1. Introduction
          1. Application By Value
        2. Nonalcoholic Steatohepatitis (NASH)
          1. By Value
        3. Chronic Kidney Disease (CKD)
          1. By Value
        4. Diabetes
          1. By Value
        5. Cardiovascular Diseases
          1. By Value
        6. Oncology
          1. By Value
        7. Neurology
          1. By Value
        8. Endocrinology
          1. By Value
        9. Dermatology
          1. By Value
        10. Hematology
          1. By Value
        11. Others
          1. By Value
      4. By End-Use
        1. Introduction
          1. End-Use By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Medical Devices Manufacturers
          1. By Value
        4. Academic and Government Research Institutes
          1. By Value
        5. Contract Research Organizations (CROs)
          1. By Value
        6. Others
          1. By Value
      5. By Distributor
        1. Introduction
          1. Distributor By Value
        2. Direct Sales
          1. By Value
        3. Tender Sales
          1. By Value
    8. Canada
    1. North America Clinical Trial Imaging Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. BioTelemetry Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. IXICO plc
    3. Resonance Health
    4. Clario
    5. ICON plc
    6. Radiant Sage LLC
    7. Quotient Sciences
    8. Worldcare Clinical
    9. Navitas Life Sciences
    10. Cardiovascular Imaging Technologies
    11. Intrinsic Imaging
    12. Perspectum Diagnostics
    13. Parexel International Corporation
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Aerial Imaging Market Size The global aerial imaging market size was valued at USD 2.54 billion in 2023. It is expected to reach from USD 2.94 in 2024 to USD 9.35 billion by 2032, growing at a CAGR of 15.57% during the forecast period (2024–20
Buy Now
Global Report
The global clinical trails site market size was valued at USD 5.61 billion in 2021 and is projected to reach USD 9.65 billion by 2030 at a CAGR of 6.22% from 2022 to 2030. Factors such as investment in R&D and rising investments, significantly dr
Buy Now
Global Report
The global clinical trial management system market size was valued at USD 1.07 billion in 2022. It is projected to reach USD 3.53 billion by 2031, growing at a CAGR of 14.2% during the forecast period (2023–2031). A custom software program cal
Buy Now
Global Report
Clinical Trials Outsourcing Market Size The global clinical trials outsourcing market size is estimated to be worth USD 47.58 billion in 2024 and is projected to reach from USD 51.57 billion in 2025 to USD 83.51 billion by 2
Buy Now
Global Report
Clinical Trials Software Market Size The global clinical trials software market size was valued at USD 1.43 billion in 2024 and is expected to grow from USD 1.65 billion in 2025 to reach USD 5.23 billion by 2033, growing at
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.